Imexpharm Corporation (HOSE:IMP)
39,800
+900 (2.31%)
At close: Aug 28, 2026
-24.19% (1Y)
| Market Cap | 6.13T -24.2% |
| Revenue (ttm) | 2.32T -4.2% |
| Net Income | 314.36B +0.7% |
| EPS | 2,041.17 +1.4% |
| Shares Out | 154.01M |
| PE Ratio | 19.50 |
| Forward PE | 17.27 |
| Dividend | 500.00 (1.35%) |
| Ex-Dividend Date | Jul 13, 2026 |
| Volume | 22,007 |
| Open | 38,950 |
| Previous Close | 38,900 |
| Day's Range | 38,950 - 41,550 |
| 52-Week Range | 32,650 - 57,000 |
| Beta | 0.41 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 16, 2026 |